Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 RNA-Based Therapeutics
1.2.3 RNA-Based Vaccines
1.3 Market by Application
1.3.1 Global RNA-Based Therapeutics and Vaccines Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Oncology
1.3.3 Immunology
1.3.4 Ophthalmology
1.3.5 Cardiovascular Diseases
1.3.6 Infectious Diseases
1.3.7 Genetic Diseases
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2018-2033)
2.2 RNA-Based Therapeutics and Vaccines Growth Trends by Region
2.2.1 Global RNA-Based Therapeutics and Vaccines Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 RNA-Based Therapeutics and Vaccines Historic Market Size by Region (2018-2023)
2.2.3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Region (2024-2033)
2.3 RNA-Based Therapeutics and Vaccines Market Dynamics
2.3.1 RNA-Based Therapeutics and Vaccines Industry Trends
2.3.2 RNA-Based Therapeutics and Vaccines Market Drivers
2.3.3 RNA-Based Therapeutics and Vaccines Market Challenges
2.3.4 RNA-Based Therapeutics and Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue
3.1.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2018-2023)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
3.4 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio
3.4.1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2022
3.5 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
3.6 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
3.7 Date of Enter into RNA-Based Therapeutics and Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-Based Therapeutics and Vaccines Breakdown Data by Type
4.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2018-2023)
4.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2024-2033)
5 RNA-Based Therapeutics and Vaccines Breakdown Data by Application
5.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Application (2018-2023)
5.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America RNA-Based Therapeutics and Vaccines Market Size (2018-2033)
6.2 North America RNA-Based Therapeutics and Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America RNA-Based Therapeutics and Vaccines Market Size by Country (2018-2023)
6.4 North America RNA-Based Therapeutics and Vaccines Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2018-2033)
7.2 Europe RNA-Based Therapeutics and Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2018-2023)
7.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size (2018-2033)
8.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2018-2023)
8.4 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA-Based Therapeutics and Vaccines Market Size (2018-2033)
9.2 Latin America RNA-Based Therapeutics and Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2018-2023)
9.4 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size (2018-2033)
10.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2018-2023)
10.4 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Detail
11.2.2 Arbutus Biopharma Business Overview
11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction
11.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.2.5 Arbutus Biopharma Recent Development
11.3 Arrowhead Pharmaceuticals
11.3.1 Arrowhead Pharmaceuticals Company Detail
11.3.2 Arrowhead Pharmaceuticals Business Overview
11.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
11.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.3.5 Arrowhead Pharmaceuticals Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Detail
11.4.2 BioNTech Business Overview
11.4.3 BioNTech RNA-Based Therapeutics and Vaccines Introduction
11.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.4.5 BioNTech Recent Development
11.5 CureVac
11.5.1 CureVac Company Detail
11.5.2 CureVac Business Overview
11.5.3 CureVac RNA-Based Therapeutics and Vaccines Introduction
11.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.5.5 CureVac Recent Development
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Detail
11.6.2 Dicerna Pharmaceuticals Business Overview
11.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
11.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.6.5 Dicerna Pharmaceuticals Recent Development
11.7 Regulus Therapeutics
11.7.1 Regulus Therapeutics Company Detail
11.7.2 Regulus Therapeutics Business Overview
11.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction
11.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.7.5 Regulus Therapeutics Recent Development
11.8 Marina Biotech
11.8.1 Marina Biotech Company Detail
11.8.2 Marina Biotech Business Overview
11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction
11.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.8.5 Marina Biotech Recent Development
11.9 MiRagen Therapeutics
11.9.1 MiRagen Therapeutics Company Detail
11.9.2 MiRagen Therapeutics Business Overview
11.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction
11.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.9.5 MiRagen Therapeutics Recent Development
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Detail
11.10.2 Moderna Therapeutics Business Overview
11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction
11.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.10.5 Moderna Therapeutics Recent Development
11.11 Quark Pharmaceuticals
11.11.1 Quark Pharmaceuticals Company Detail
11.11.2 Quark Pharmaceuticals Business Overview
11.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
11.11.4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.11.5 Quark Pharmaceuticals Recent Development
11.12 Roche
11.12.1 Roche Company Detail
11.12.2 Roche Business Overview
11.12.3 Roche RNA-Based Therapeutics and Vaccines Introduction
11.12.4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.12.5 Roche Recent Development
11.13 Sylentis
11.13.1 Sylentis Company Detail
11.13.2 Sylentis Business Overview
11.13.3 Sylentis RNA-Based Therapeutics and Vaccines Introduction
11.13.4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023)
11.13.5 Sylentis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of RNA-Based Therapeutics
Table 3. Key Players of RNA-Based Vaccines
Table 4. Global RNA-Based Therapeutics and Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global RNA-Based Therapeutics and Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global RNA-Based Therapeutics and Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global RNA-Based Therapeutics and Vaccines Market Share by Region (2018-2023)
Table 8. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global RNA-Based Therapeutics and Vaccines Market Share by Region (2024-2033)
Table 10. RNA-Based Therapeutics and Vaccines Market Trends
Table 11. RNA-Based Therapeutics and Vaccines Market Drivers
Table 12. RNA-Based Therapeutics and Vaccines Market Challenges
Table 13. RNA-Based Therapeutics and Vaccines Market Restraints
Table 14. Global RNA-Based Therapeutics and Vaccines Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global RNA-Based Therapeutics and Vaccines Market Share by Players (2018-2023)
Table 16. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2022)
Table 17. Ranking of Global Top RNA-Based Therapeutics and Vaccines Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by RNA-Based Therapeutics and Vaccines Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
Table 21. Date of Enter into RNA-Based Therapeutics and Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global RNA-Based Therapeutics and Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2018-2023)
Table 25. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2024-2033)
Table 27. Global RNA-Based Therapeutics and Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application (2018-2023)
Table 29. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application (2024-2033)
Table 31. North America RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America RNA-Based Therapeutics and Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America RNA-Based Therapeutics and Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 46. Alnylam Pharmaceuticals Company Detail
Table 47. Alnylam Pharmaceuticals Business Overview
Table 48. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
Table 49. Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 50. Alnylam Pharmaceuticals Recent Development
Table 51. Arbutus Biopharma Company Detail
Table 52. Arbutus Biopharma Business Overview
Table 53. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product
Table 54. Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 55. Arbutus Biopharma Recent Development
Table 56. Arrowhead Pharmaceuticals Company Detail
Table 57. Arrowhead Pharmaceuticals Business Overview
Table 58. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
Table 59. Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 60. Arrowhead Pharmaceuticals Recent Development
Table 61. BioNTech Company Detail
Table 62. BioNTech Business Overview
Table 63. BioNTech RNA-Based Therapeutics and Vaccines Product
Table 64. BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 65. BioNTech Recent Development
Table 66. CureVac Company Detail
Table 67. CureVac Business Overview
Table 68. CureVac RNA-Based Therapeutics and Vaccines Product
Table 69. CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 70. CureVac Recent Development
Table 71. Dicerna Pharmaceuticals Company Detail
Table 72. Dicerna Pharmaceuticals Business Overview
Table 73. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
Table 74. Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 75. Dicerna Pharmaceuticals Recent Development
Table 76. Regulus Therapeutics Company Detail
Table 77. Regulus Therapeutics Business Overview
Table 78. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product
Table 79. Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 80. Regulus Therapeutics Recent Development
Table 81. Marina Biotech Company Detail
Table 82. Marina Biotech Business Overview
Table 83. Marina Biotech RNA-Based Therapeutics and Vaccines Product
Table 84. Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 85. Marina Biotech Recent Development
Table 86. MiRagen Therapeutics Company Detail
Table 87. MiRagen Therapeutics Business Overview
Table 88. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product
Table 89. MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 90. MiRagen Therapeutics Recent Development
Table 91. Moderna Therapeutics Company Detail
Table 92. Moderna Therapeutics Business Overview
Table 93. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product
Table 94. Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 95. Moderna Therapeutics Recent Development
Table 96. Quark Pharmaceuticals Company Detail
Table 97. Quark Pharmaceuticals Business Overview
Table 98. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
Table 99. Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 100. Quark Pharmaceuticals Recent Development
Table 101. Roche Company Detail
Table 102. Roche Business Overview
Table 103. Roche RNA-Based Therapeutics and Vaccines Product
Table 104. Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 105. Roche Recent Development
Table 106. Sylentis Company Detail
Table 107. Sylentis Business Overview
Table 108. Sylentis RNA-Based Therapeutics and Vaccines Product
Table 109. Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2018-2023) & (US$ Million)
Table 110. Sylentis Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA-Based Therapeutics and Vaccines Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global RNA-Based Therapeutics and Vaccines Market Share by Type: 2022 VS 2033
Figure 3. RNA-Based Therapeutics Features
Figure 4. RNA-Based Vaccines Features
Figure 5. Global RNA-Based Therapeutics and Vaccines Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2022 VS 2033
Figure 7. Oncology Case Studies
Figure 8. Immunology Case Studies
Figure 9. Ophthalmology Case Studies
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Genetic Diseases Case Studies
Figure 13. Others Case Studies
Figure 14. RNA-Based Therapeutics and Vaccines Report Years Considered
Figure 15. Global RNA-Based Therapeutics and Vaccines Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global RNA-Based Therapeutics and Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global RNA-Based Therapeutics and Vaccines Market Share by Region: 2022 VS 2033
Figure 18. Global RNA-Based Therapeutics and Vaccines Market Share by Players in 2022
Figure 19. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by RNA-Based Therapeutics and Vaccines Revenue in 2022
Figure 21. North America RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America RNA-Based Therapeutics and Vaccines Market Share by Country (2018-2033)
Figure 23. United States RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe RNA-Based Therapeutics and Vaccines Market Share by Country (2018-2033)
Figure 27. Germany RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Share by Region (2018-2033)
Figure 35. China RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America RNA-Based Therapeutics and Vaccines Market Share by Country (2018-2033)
Figure 43. Mexico RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Share by Country (2018-2033)
Figure 47. Turkey RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 50. Arbutus Biopharma Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 51. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 52. BioNTech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 53. CureVac Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 54. Dicerna Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 55. Regulus Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 56. Marina Biotech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 57. MiRagen Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 58. Moderna Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 59. Quark Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 60. Roche Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 61. Sylentis Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed